Strong Growth Ahead: Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Size To Grow At Arecord 6.8% Cagr By 2029

The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Size Expected to Be by 2034?
The bioinformatics in in-vitro diagnostics (IVD) testing market has seen strong growth in recent years. It will grow from $93.02 billion in 2024 to $99.69 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. This growth is attributed to improved healthcare infrastructure, the expansion of biobanks, a growing geriatric population, government initiatives and funding, and the growth of personalized medicine.

The bioinformatics in in-vitro diagnostics (IVD) testing market is projected to grow to $129.89 billion by 2029 at a CAGR of 6.8%. The market's expansion is fueled by the rising prevalence of diseases, healthcare IT integration, government initiatives, personalized medicine, awareness of bioinformatics' role in diagnostics, and reduced genomic sequencing costs. Trends include AI and machine learning, next-gen sequencing, POC testing, cloud computing, big data, and immunochemical innovations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16629

What Are the Emerging Segments Within the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
The bioinformatics in in-vitro diagnostics (IVD) testing market covered in this report is segmented -

1) By Type: Hardware, Software
2) By Type Of Test: Blood Based Tests, Tissue Based Tests
3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Other Applications

Subsegments:
1) By Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors And Detectors, Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics And Interpretation Software, Cloud-Based Software Solutions, AI-Based Software For Diagnostics

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp

What Long-Term Drivers Are Shaping Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Trends?
The rising prevalence of cancer is expected to drive the growth of the bioinformatics in IVD testing market. Cancer, marked by abnormal cell growth, is increasingly prevalent due to exposure, lifestyle, and environmental factors. Bioinformatics in IVD testing improves cancer diagnostics by offering genetic insights that enhance early detection, treatment decisions, and outcomes. For instance, in 2022, the National Association of Chronic Disease Directors reported that 40% of American adults have multiple chronic conditions, elevating the risk of cancer. This rising cancer prevalence drives the bioinformatics in IVD testing market.

Who Are the Top Competitors in Key Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Segments?
Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.

What Trends Are Expected to Dominate the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market in the Next 5 Years?
Companies in the bioinformatics in the IVD testing market are developing innovative solutions like next-generation sequencing (NGS) technology to improve the detection of genetic mutations and support personalized medicine. NGS allows for high-throughput sequencing of genomes or specific DNA and RNA regions. For example, in May 2022, Illumina Inc., a US-based biotechnology company, launched the TruSight Oncology Comprehensive test for pan-cancer diagnostics. This test identifies cancer patients with NTRK gene fusions who may benefit from targeted therapies, providing comprehensive genetic profiling from a single biopsy.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report

Which Regions Are Becoming Hubs for Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Innovation?
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
2. What is the CAGR expected in the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
3. What Are the Key Innovations Transforming the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Industry?
4. Which Region Is Leading the Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.